全文获取类型
收费全文 | 1362篇 |
免费 | 71篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 17篇 |
妇产科学 | 8篇 |
基础医学 | 93篇 |
口腔科学 | 7篇 |
临床医学 | 272篇 |
内科学 | 124篇 |
皮肤病学 | 3篇 |
神经病学 | 43篇 |
特种医学 | 69篇 |
外科学 | 201篇 |
综合类 | 197篇 |
预防医学 | 92篇 |
眼科学 | 7篇 |
药学 | 226篇 |
中国医学 | 37篇 |
肿瘤学 | 47篇 |
出版年
2023年 | 10篇 |
2022年 | 28篇 |
2021年 | 28篇 |
2020年 | 42篇 |
2019年 | 38篇 |
2018年 | 20篇 |
2017年 | 21篇 |
2016年 | 31篇 |
2015年 | 34篇 |
2014年 | 97篇 |
2013年 | 107篇 |
2012年 | 92篇 |
2011年 | 97篇 |
2010年 | 96篇 |
2009年 | 71篇 |
2008年 | 62篇 |
2007年 | 57篇 |
2006年 | 54篇 |
2005年 | 53篇 |
2004年 | 39篇 |
2003年 | 26篇 |
2002年 | 41篇 |
2001年 | 26篇 |
2000年 | 26篇 |
1999年 | 30篇 |
1998年 | 21篇 |
1997年 | 27篇 |
1996年 | 21篇 |
1995年 | 24篇 |
1994年 | 17篇 |
1993年 | 11篇 |
1992年 | 11篇 |
1991年 | 9篇 |
1990年 | 8篇 |
1989年 | 3篇 |
1988年 | 5篇 |
1987年 | 3篇 |
1986年 | 9篇 |
1985年 | 5篇 |
1984年 | 5篇 |
1983年 | 4篇 |
1982年 | 6篇 |
1981年 | 4篇 |
1979年 | 6篇 |
1977年 | 3篇 |
1976年 | 2篇 |
1975年 | 3篇 |
1973年 | 3篇 |
1972年 | 2篇 |
1970年 | 3篇 |
排序方式: 共有1448条查询结果,搜索用时 15 毫秒
1.
2.
3.
目的:评价持续靶控输注异丙酚复合硬膜外阻滞有用于上腹部手术的可行性。方法:30例胃癌手术患者,ASAⅠ~Ⅱ级。随机分成靶控输注异丙酚全麻(T)组15例,靶控异丙酚复合硬膜外阻滞(T+E)组15例。结果:(T+E)组术后躁动、芬太尼、丙泊酚的用量低于(T)组(P<0.05)。异丙酚单位标准化剂量亦较低。两组苏醒时间相似。诱导后两组血压均显著下降(P<0.05),T+E组在诱导后DBP的下降幅度较T组更为显著(P<0.05),T组在探查、术毕、拨管后的SBP、DBP、MAP比(T+E)组显著增高(P<0.05)。两组诱导后至术毕BIS、SEF显著下降,两组间的比较无统计学意义(P>0.05)。结论:靶控输注异丙酚复合硬膜外阻滞用于上腹部手术是可行的,具有异丙酚、芬太尼的用量少、苏醒快、术后躁动少,麻醉深度易于调控,血液动力学较稳定,是一种良好的麻醉方式。 相似文献
4.
临床输液监控系统的设计 总被引:5,自引:0,他引:5
本文针对临床输液过程中出现的漏、停、输液速度改变等各种问题,讨论了一由单台微机和多个单片机通讯实现的多床输液自动监控、自动反应、自动报答系统的可行性,并给出了主要部分的硬件、软件设计方法。 相似文献
5.
Staffan Eksborg Lennart Hardell Nils-Olof Bengtsson Marie Sjödin Birgitta Elfsson 《Medical oncology (Northwood, London, England)》1992,9(2):75-80
Sixty women with breast cancer (mean age: 61 years; range 36-78 years) were treated with Epirubicin (4’epi-Dox-orubicin),
60 mg m-2 , as single drug therapy. The drug was administered as 2 hours’ constant rate infusions. The pharmacokinetics of the drug
during the first course of treatment was evaluated by measurements of the plasma concentration of Epirubicin at the end of
the infusion period.
There was a five-fold inter-individual variation of the dose-normalized maximum plasma concentration, which increased with
increasing age of the patients. There was no correlation between this pharmacokinetic parameter and degree of obesity. 相似文献
6.
7.
Andreas Reichenbach Wolfgang Eberhardt 《Pflügers Archiv : European journal of physiology》1986,407(3):348-353
Müller (glial) cells were isolated from rabbit retinae by papaine and mechanical dissociation. The cells were fixed on a gelatine-covered glass slide by means of concanavalin A, and the slide was mounted in a perfusion chamber under a light microscope with modified optics. Besides the recording microelectrode, two other micropipettes could be adjusted with their tips near the cell. These micropipettes were used for application of test solutions into the environment of the cells. On application of high K+ solutions, the cell depolarized strongly but during prolonged application there was a marked repolarization. After the end of high K+ application the cells showed a hyperpolarization which was enhanced in both amplitude and duration with prolongation of the K+ exposure. Both repolarization and afterhyper-polarization disappeared under ouabain. Ouabain application itself caused a small reversible depolarization. Na+ free solution caused hyperpolarization. The results suggest the existence of an active membrane pump mechanism in our cells. This pump seems to be electrogenic under our experimental conditions and seems to be activated even in the absence of sodium. The cell membrane is demonstrated to contain a significant Na+ conductance. 相似文献
8.
David J Stewart MD FRCP Michael T Richard Herman Hugenholtz Jean Dennery Dev Nundy Judith Prior Vital Montpetit Harry S Hopkins 《Journal of neuro-oncology》1984,2(4):315-324
Thirty-four consenting patients received VM-26 50–100 mg/m2 I.V. before surgical resection of intracerebral tumor, and drug was measured using a high pressure liquid chromatographic technique. Sufficient tumor for analysis was obtained from 29 patients. Brain metastases (13 patients) had higher concentrations of V M-26 than did gliomas (13 patients). Concentrations were comparable in brain metastases and meningiomas (3 patients). Prolonged (24 h) infusion of V M-26 did not appear to result in higher tumor drug concentrations in 5 patients than did rapid (1 h) infusion in 24 patients. Pretreatment with Amphotericin-B 10 mg/m2 12 h and 1 h before VM-26 did not appear to have any effect on VM-26 uptake into 4 intracerebral tumors, although data were limited, and VM-26 concentrations were very high in 1 metastasis. Pretreatment with oral glycerol 500 mg/kg 18 h, 12 h, 6 h, and immediately before I.V. VM-26 may have resulted in increased penetration of VM-26 into 9 tumors, although confirmation is required. Amphotericin-B, glycerol, and operative conditions did not appear to alter VM-26 plasma pharmacokinetics.VM-26
4-demethylepipodophyllotoxin 9-(4-6-O-thenylidene-B-D-glucopyranoside)
- VP-16
4-demethylepipodophyllotoxin 9-(4-6-O-ethylidene-B-D-glucopyranoside)
Presented in Part at the 74th Annual Meeting of the American Association for Cancer Research, San Diego, California, May 25–28, 183(1). 相似文献
9.
A. A. T. M. M. Vinks D. J. Touw R. C. J. M. van Rossen H. G. M. Heijerman W. Bakker 《Pharmacy World & Science》1996,18(2):74-77
The stability of the monocyclic -lactam antibiotic aztreonam in portable pump reservoirs was studied during storage at temperatures of-20°C and +5°C and during drug delivery at 37°C. Three 100-ml drug reservoirs and three glass containers containing 60 mg/ml aztreonam were stored at-20°C and 2-ml samples were analysed in the freshly prepared solution and after thawing at days 7, 21, 28, 70 and after 6 months of storage. A separate triplicate batch of 100-ml prefilled drug reservoirs and glass containers containing a similar aztreonam concentration (60 mg/ml) were refrigerated and tested immediately after preparation and daily for 8 days and after 70 days. Solutions of aztreonam in duplicate freshly prepared reservoirs were tested for stability when the solution was pumped at 37°C over a 24-h period. All solutions were inspected for visual changes and tested for pH. Drug concentration was analysed by high-performance liquid chromatography. No colour changes or pH differences were observed in any of the solutions in the reservoirs or containers. No statistically significant decrease in aztreonam concentration could be detected after 6 months of storage at-20°C. Aztreonam was stable at 5°C for at least 8 days. A 24-h pumping period at 37°C showed a 3.6% decrease in aztreonam concentration. Aztreonam at a concentration of 60 mg/ml in a pump reservoir is sufficiently stable to be used in home intravenous antibiotic treatment programmes. 相似文献
10.
目的本研究观察经肝动脉栓塞化疗和(或)肝动脉插管持续灌注化疗治疗晚期胃肠癌肝转移的临床疗效.方法 22例无外科手术指征的晚期胃肠癌肝转移患者经肝动脉介入治疗共72次,单采取Seldinger法肝动脉内插管皮下埋置药盒持续灌注化疗48次,或先用吡柔比星(THP)60 mg/m2和DDP 50 mg/m2加入超液化碘油10~30 ml进行肝动脉栓塞化疗再联合肝动脉持续灌注化疗共24次.肝动脉插管灌注的方案:CF 200 mg/m2,d1,d14,静脉滴入;顺铂(DDP)50 mg/m2,d1,或用奥沙利铂100~130 mg/m2,d1,从皮下药盒处缓慢推入;5-Fu 2 000~2 500 mg/m2,d1,d14,装入美国百特公司的便携式输液泵持续动脉灌注48 h.结果总有效率(完全缓解 部分缓解)为59.0%.肿瘤负荷<30%者的有效率为77.8%,明显高于肿瘤负荷>30%者(46.2%,P<0.005).本组患者主要不良反应为肝功能损害、发热及胃肠道反应等,经相应对症处理可缓解.结论经肝动脉栓塞及插管持续化疗是治疗胃肠癌肝转移的安全有效方法,值得临床推广. 相似文献